Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.

Hirofumi MukaiTakeshi YamaguchiMasato TakahashiYasuo HozumiTomomi FujisawaShozo OhsumiHiromitsu AkabaneReiki NishimuraTsutomu TakashimaYoungjin ParkYasuaki SagaraTatsuya ToyamaShigeru ImotoToshiro MizunoSatoshi YamashitaSatoshi FujiiYukari Uemura

Published in: British journal of cancer (2020)

Clinical Trial Registration: UMIN-CTR as UMIN000007074.

Keyphrases

positive breast cancer
clinical trial
open label
double blind
phase ii
placebo controlled
phase iii
study protocol
patients undergoing
locally advanced
neoadjuvant chemotherapy
lymph node